NASDAQ
No price data available for this timeframe.
Corvus Pharmaceuticals, Inc. (CRVS) has a interest coverage ratio of 0.00x as of Friday, May 29, 2026. This represents a 100.00% increase compared to its 12-month average of -643.83x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.